Patents expiring in 2029

US 7534418

Imaging agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534775

Methods and compositions for modulating cardiac contractility

Sangamo Biosciences, Inc. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534887

Thiazoline derivative and use of the same

Takeda Pharmaceutical Company Limited · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534913

Crystalline form of nateglinide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534900

Process for the purification of duloxetine hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534859

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534889

5-HT4 receptor agonist compounds

Theravance, Inc. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534604

Fusion polypeptides capable of activating receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534764

Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534761

Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom

Northwestern University · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534613

Methods of treating parkinson's disease using viral vectors

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534595

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534565

DLC-1 gene deleted in cancers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538133

Benzimidazole derivatives, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538097

Inhibition of antigen presentation with poorly catabolized polymers

HALOZYME, INC. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538108

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537759

Modulating angiogenesis

The Regents of the University of California · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537765

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537421

Dead spindle PTO with compliant grounding mechanism

BLACK & DECKER INC. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538183

HPV vaccine comprising peptides from host cell proteins

University College Cardiff Consultants Limited · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538189

Methods of making deuterated cyclosporin analogs

Isotechnika, Inc. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538136

Crystalline forms of atorvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538129

Diazonamide A analog

The Board of Regents of the University of Texas System · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537791

Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production

INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537923

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538125

Pharmaceutical composition

Takeda Pharmaceutical Company Limited · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

AR 065278

SALES DE DERIVADO DE BENZOTIAZOL

ASTRAZENECA AB [SE] · Granted Wed May 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

AR 065277

COMBINACIONES DE BENZOTIAZOLONA AGONISTA 2-BETA-ADRENOCEPTOR

ASTRAZENECA AB [SE] · Granted Wed May 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2061775

SPIRO-OXAZOLIDINON-VERBINDUNGEN UND IHRE VERWENDUNG ALS VERSTÄRKER METABOTROPER GLUTAMATREZEPTOREN

ASTRAZENECA AB [SE] · Granted Wed May 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2008328307

5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

ASTRAZENECA AB [SE] · Granted Thu May 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541040

Chimeric molecule for the treatment of th2-like cytokine mediated disorders

The United States of America as represented by the Department of Health and Human Serivces · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541346

Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541381

Non-covalent inhibitors of AmpC β-lactamase

Northwestern University · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541429

Comparative ligand mapping from MHC positive cells

The Board of Regents of the University of Oklahoma · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541463

Sulfur-containing naphthalimide derivatives

East China University of Science and Technology · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541478

Coumarin derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541331

Surfactant treatment regimen

Discovery Laboratories, Inc. · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541043

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541035

Immunogenic peptides for the treatment of prostate and breast cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2064340

VERFAHREN ZUR BEWERTUNG VON PATIENTEN BEI DER BEHANDLUNG MIT AUF RET-REZEPTOR-TYROSINKINASE ABZIELENDEN ARZNEISTOFFEN

ASTRAZENECA AB [SE] · Granted Wed Jun 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544364

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

Theravance, Inc. · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544358

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544499

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

HALOZYME, INC. · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544481

Nucleic acids encoding CD40 binding protein

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544789

DNA encoding Toxoplasma gondii rDGP5p protein

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)